Literature DB >> 3784295

Plasma free, sulfo- and glucuro-conjugated catecholamines in uremic patients.

J L Cuche, J Prinseau, F Selz, G Ruget, A Baglin.   

Abstract

The metabolism of catecholamines (CA) in non-selected patients with chronic renal failure and under hemodialysis (CRFh) was studied by measuring the concentration of plasma free, sulfo- and glucuroconjugated CA, dopamine (DA), norepinephrine (NE), and epinephrine (EPI). Our data demonstrate a statistically significant increase of free DA and free NE concentration in CRFh, while that of free EPI was not different from controls. However a careful scrutiny of 35 individual data suggests that sub-groups of patients with either high normal or low plasma-free NE concentration could exist; this likely heterogeneity could be a good explanation for conflicting conclusions provided by previous reports. Suspecting that conjugated CA might be altered in CRFh, plasma sulfo- and glucuro-conjugated DA, NE and EPI were also measured. We have found a predictable and highly significant increase of sulfo-conjugated CA; plasma concentration of glucuro-conjugated DA and NE in CRFh was not different from controls, while that of glucuro-conjugated EPI was significantly increased. The physiological meaning, if any, of these new observations on conjugated CA cannot be assessed at the moment. The effects of hemodialysis were also investigated. Measurements on the arterial and on the venous line showed highly significant differences for tyrosine, free and sulfo-conjugated CA, and a lack of difference for glucuro-conjugated CA. Thus tyrosine, free and sulfo-conjugated CA were eliminated by the artificial kidney, but not glucuro-conjugated amines.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3784295     DOI: 10.1038/ki.1986.222

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

Review 1.  Understanding catecholamine metabolism as a guide to the biochemical diagnosis of pheochromocytoma.

Authors:  G Eisenhofer; T T Huynh; M Hiroi; K Pacak
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

Review 2.  The role of the kidney and the sympathetic nervous system in hypertension.

Authors:  Philip Thomas; Indranil Dasgupta
Journal:  Pediatr Nephrol       Date:  2014-03-08       Impact factor: 3.714

Review 3.  Neurogenic factors in renal hypertension.

Authors:  Vito M Campese; Ewa Krol
Journal:  Curr Hypertens Rep       Date:  2002-06       Impact factor: 5.369

Review 4.  Pathophysiology and Potential Non-Pharmacologic Treatments of Obesity or Kidney Disease Associated Refractory Hypertension.

Authors:  Thierry H Le Jemtel; William Richardson; Rohan Samson; Abhishek Jaiswal; Suzanne Oparil
Journal:  Curr Hypertens Rep       Date:  2017-02       Impact factor: 5.369

5.  Atrial natriuretic peptide and sodium homeostasis in chronic renal failure.

Authors:  T Tulassay; W Rascher; K Schärer
Journal:  Pediatr Nephrol       Date:  1989-10       Impact factor: 3.714

6.  Nitric oxide (NO) modulates the neurogenic control of blood pressure in rats with chronic renal failure (CRF).

Authors:  S Ye; S Nosrati; V M Campese
Journal:  J Clin Invest       Date:  1997-02-01       Impact factor: 14.808

7.  Sympathetic renal innervation and resistant hypertension.

Authors:  Vito M Campese; Elaine Ku; Jeanie Park
Journal:  Int J Hypertens       Date:  2011-01-20       Impact factor: 2.420

8.  Cardiovascular risk in chronic kidney disease: role of the sympathetic nervous system.

Authors:  Jeanie Park
Journal:  Cardiol Res Pract       Date:  2012-08-07       Impact factor: 1.866

Review 9.  [Sympathetic overactivity and the kidney].

Authors:  Antje Habicht; Bruno Watschinger
Journal:  Wien Klin Wochenschr       Date:  2003-09-30       Impact factor: 2.275

10.  Associations between sympathetic activity, plasma concentrations of renin, aldosterone, and parathyroid hormone, and the degree of intractability of blood pressure control in modialysis patients.

Authors:  Zoong Rock Hong; Hyo Wook Gil; Jong Oh Yang; Eun Young Lee; Jae Ouk Ahn; Sae Yong Hong
Journal:  J Korean Med Sci       Date:  2007-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.